UNSPSC 51351701: Drospirenone

This classification denotes a therapeutic progestin with the molecular formula C24H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N295J34A25, chemically known as 1,2-dihydrospirorenone but generally known as drospirenone, which bears US NIH Compound Identifier 68873. European Medicines Agency schedules Drospirenone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06413MIG.

UNSPSC 51351701 Drospirenone is a Commodity code representing a specific pharmaceutical active ingredient used in contraceptive and hormone-replacement formulations. State and local governments procure drospirenone-containing products as part of broader pharmaceutical supply agreements for public health agencies, correctional facilities, and state Medicaid programs. The work being solicited under this code reflects demand from multi-jurisdictional cooperative purchasing groups seeking to stock and distribute FDA-approved generic and branded pharmaceuticals across participating member agencies, with vendors required to meet cGMP certification, DSCSA compliance, and established relationships with major pharmaceutical wholesalers.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal (S1070000015802) on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products, with Oregon as a participating state and proposals due March 26, 2026. Vendors must supply through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with pricing weighted at 75 percent of the evaluation score, compliance with administrative fee data format and EDI capability at 5 percent each, fixed pricing at 10 percent, and agreement to a 3 percent administrative fee at 5 percent. The contract term runs two years with optional extensions, and awarded vendors will be effective July 1, 2026, with performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding, or improper class-of-trade denials.